Advancement in biotechnology provided a notable expansion of peptide and protein
therapeutics, used as antigens, vaccines, hormones. It has a prodigious potential to treat a …

To improve liposomes' usage as drug delivery vehicles, cryoprotectants can be utilized to
prevent constituent leakage and liposome instability. Cryoprotective agents (CPAs) or …

Nanotechnology is a multidisciplinary domain that involves overlapping areas such as
nanomaterials, nanoelectronics, and nanobiotechnology. Herbal medicine is a significant …

In vitro cell-based characterization methods of nanoparticles are generally static and require
the use of secondary analysis techniques and labeling agents. In this study, bare niosomes …

Liposome was discovered earliest in the year 1961 by Dr. Alec Bangham, a British
hematologist who tried this delivery system for transporting bioactive substances …

Polymeric nanoparticles (NPs) are tiny particles with a diameter ranging from of 1 to 1000
nm that can be loaded with active compounds or surface-adsorbed onto the polymeric core …

In the last two decades, several promising engineered nanomaterials that combine
therapeutic features and imaging functionalities have been presented, but very few have …

In the current advancement of drug delivery systems, nanoliposome vesicles act as a
modernized technology for the encapsulation of bioactive agents. The prerequisite to …

New nanotechnology tactics to enhance drug delivery to the central nervous system have
drawn increasing attention from academics and drug designers in recent years (CNS). The …

Glaucoma affects millions worldwide. Untreated, it might cause lifelong blindness.
Traditional treatments have been limited and intrusive. Liposomes are changing glaucoma …